A Test in Focus

Chromosomal Microarray, Prenatal, Amniotic Fluid/Chorionic Villus Sampling is a high-resolution method for detecting copy number changes (gains or losses) across the entire genome in a single assay. Umut Aypar, Ph.D., provides a video overview of this test.

By Alyssa Frank • April 27, 2016

Cytochrome P450 2C19 (encoded by the gene CYP2C19) is a liver enzyme that participates in the activation of the anticoagulant clopidogrel (Plavix) and metabolism of other drugs, such as citalopram. As a result, Clopidrigrel may be less effective in altering platelet activity in those people, who may remain at risk for heart attack, stroke, and cardiovascular death.

By Alyssa Frank • March 31, 2016

Six new next-generation sequencing (NGS) panels for the evaluation of hereditary peripheral neuropathies are now […]

By Brent Westra • March 15, 2016

The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

By Brent Westra • March 10, 2016

This one-hour “Specialty Testing” webinar will examine Lp-PLA2 and the benefits of ordering the Lipoprotein-Associated Phospholipase A2 Activity Test (Mayo ID: PLACA) offered by Mayo Medical Laboratories.Tuesday, November 24, 2015 | 2:00 p.m. – 3:00 p.m. CST

By Brent Westra • November 17, 2015

The new Phospholipase A2 Receptor Antibodies, Serum, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test can be used to help distinguish primary from secondary membranous nephropathy. However, it should not be used as a stand-alone test but an adjunct to other clinical information.

By Alyssa Frank • October 8, 2015

The new GRHPR Gene, Full Gene Analysis, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

By Brent Westra • September 9, 2015

The new Lipoprotein-Associated Phospholipase A2 Activity, Serum, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

By Brent Westra • July 28, 2015

The new Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test should be ordered to assess a trough level quantitation for evaluation of patients with loss of response to infliximab.

By Brent Westra • May 13, 2015

The new RAS/RAF Targeted Gene Panel by Next Generation Sequencing, Tumor, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. In this post, Dr. Ande Rumilla discusses the clinical significance, proper ordering scenarios, and the science behind the test.

By Brent Westra • January 13, 2015

The new Histoplasma Antigen, Urine test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test should be ordered in individuals suspected to be infected with Histoplasma capsulatum.

By Brent Westra • August 22, 2014

A new dementia autoimmune evaluation is now available. View this post to learn what providers should know about autoimmune dementia, our testing approach, as well as interpretation, follow-up, and additional considerations once the test has been ordered.

By Brent Westra • July 30, 2014

A new encephalopathy autoimmune evaluation is now available. View this post to learn what providers should know about autoimmune encephalopathy, our testing approach, as well as interpretation, follow-up, and additional considerations once the test has been ordered.

By Brent Westra • July 21, 2014